consumer genomics

By Dave Muoio November 15, 2018
Tattoo circuits. Researchers from Carnegie Mellon University and the University of Coimbra have unveiled a method of printing thin circuits that could better enable wearable computation. The low-cost alloy is attached to a stretchable tattoo paper that adheres to the skin when wet, similarly to the decorative tattoos worn by children. "This is a breakthrough in the printed electronics area,"...

Photo credit: Helix

By Laura Lovett October 19, 2018
Yesterday morning Helix, an early player in the consumer genomics field, announced the launch of its DNA Product Studio. The tool aims to boost the development of new genomics apps and tests for Helix’s partners.  Helix’s model uses third party partners that are experts in a specific arena to develop products. Meanwhile Helix provides sample collection, DNA sequencing, and secures data that the...
By Laura Lovett September 10, 2018
From ancestry to wine pallet preferences, consumer genomics have fueled both popular curiosity and public discourse. Now MyVytalics, a relative newcomer in the space that focuses on healthy aging, is teaming up with major player in the consumer genomics space Helix to release a new personal genomics app that will look at how genes play in to sleep patterns and nutrition. In the future, the two...
By Dave Muoio August 24, 2018
23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports. While the raw data will remain available to clinical research partners such as GlaxoSmithKline, which invested $300 million this year to gain access to the genetic testing startup’s DNA database for drug...
23andMe lands $300 million investment from GlaxoSmithKline

23andMe kits at a Beverly Hills event in 2017. Credit: Matt Winkelmeyer, Getty Images

By Bernie Monegain July 25, 2018
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.  The deal comes as GlaxoSmithKline amid reports that GSK is weighing the possibility of a company breakup and investors contending that synergies between consumer markets and big pharma are inherently limited and that GSK’s pharmaceuticals business...

Scientist working in the lab at Helix. Photo courtesy of Helix. 

By Laura Lovett June 15, 2018
In the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healthcare space.    Whether it is uniting women switched at birth 72-years prior or settling neighborly feuds, consumer genomics have caught the public’s interest. The highest...
By Jonah Comstock June 4, 2018
As of tomorrow, individual genetic risk tests are officially exempt from requiring 510(k) premarket approval, provided the company offering the test has gone through a one-time premarket review of its testing apparatus and at least one test. The notice, which will be officially published tomorrow in the Federal Registry, finalizes a guidance that was originally proposed in November 2017. "Today,...
By Jonah Comstock January 4, 2018
Consumer gene testing company 23andMe is launching a large online study on the relationship between genetics and weight loss behaviors. Drawing volunteer subjects from its existing customers, the company will investigate three different weight loss strategies in a study that hopes to recruit 100,000 participants. "This is to my knowledge the first example of a genome-wide association study for...
By Laura Lovett November 28, 2017
Senator Chuck Schumer (D-New York) is warning consumers to think before they buy mail-order DNA testing services this holiday season.  Schumer cautions that these test kits put consumer privacy at risk because DNA firms could potentially sell personal and genetic information. Now Schumer is calling on the Federal Trade Commission to investigate and ensure that the privacy policies are clear,...
By Jonah Comstock November 7, 2017
FDA Commissioner Scott Gottlieb announced today that the agency intends to make a major change to its regulatory process around direct-to-consumer genetic health risk (GHR) tests. Specifically, the agency is creating a framework that will allow companies to bypass premarket certification for individual tests once they submit to a one-time review of their processes, an approach reminiscent of the...
виагра таблетки применение

купить таблетки сиалис

www.rs-clinic.com.ua